evolcSign inStart free
Menu

Engivent

Programmable microfluidic and automation systems for biology and biotechnology research teams

Cambridge, United KingdomFounded 2024engivent.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2024
  • New on EvolcAdded 2026-11-03

About Engivent

Engivent develops modular microfluidic systems, laboratory automation and orchestration software for programmable biological experimentation.

Its platform is designed for pharmaceutical discovery, protein and enzyme engineering, AI protein design validation, synthetic biology and microbial engineering teams. Products include microfluidic chips, fluidics modules, robotics integrations, sensing and readout systems, and workflow software.

ENGIVENT LTD is a UK company founded in 2024 and headquartered in Cambridge. It welcomes speculative applications for full-time, part-time and contract roles.

Product: Modular microfluidic and laboratory automation systems with software for programmable biological workflows.

Jobs at Engivent

No open positions listed right now.

More biotech & pharma companies

  • Ensocell

    AI-driven discovery of precision therapies for fibrotic and autoimmune diseases using human biological data
    Cambridge, United KingdomBiotech & pharmaFounded 20231 open job
    Young companyNew on Evolc

  • Enterobiotix

    Clinical-stage microbiome therapeutics developing the oral drug EBX-102-02 for irritable bowel syndrome and related gut and liver diseases
    Bellshill, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

  • Enterprise Therapeutics

    Develops investigational medicines for people with cystic fibrosis and other respiratory diseases
    Brighton, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Envision Pharma

    Medical affairs, market access and commercialization services plus AI platforms for pharma and biotech companies
    Horsham, United KingdomBiotech & pharmaFounded 2002
    New on Evolc

  • Epidarex Exeed

    Seeds early-stage life science ventures by developing breakthrough therapeutic research into investable assets
    Edinburgh, United KingdomBiotech & pharmaFounded 2019
    New on Evolc

  • Epitopea

    Develops off-the-shelf RNA cancer immunotherapies for patients with difficult-to-treat cancers
    Cambridge, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

No confirmed website technologies in the latest recorded checks.

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.